HZNP News and Press, Horizon Therapeutics Public Limited Company From 06/30/23

-- Study shows subclinical spinal cord lesions were associated with future NMOSD attacks -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of a new analysis of MRI data from the Phase 3 clinical trial of UPLIZNA showing a reduction in the formation of subclinic...

2023-06-30 08:25:48 ET Summary Despite facing regulatory challenges and competition from biosimilar products, biotech giant Amgen is seen as an attractive investment opportunity due to its high dividend yield of 3.9%, strong business performance, and expected free cash flow. The c...

2023-06-29 15:43:11 ET Pfizer ( NYSE: PFE ) believes it's likely that that the Federal Trade Commission will ask for a second request regarding its planned purchase of Seagen ( NASDAQ: SGEN ), according to a Goldman analyst who recently spoke to the Pfizer chief financial of...

2023-06-29 12:45:00 ET Biotech heavyweight Amgen (NASDAQ: AMGN) will probably continue to be an active player in the merger and acquisition (M&A) scene, regardless of what happens with its proposed $28 billion buyout of Horizon Therapeutics (NASDAQ: HZNP) . Even with...

-- First and only medicine approved in Brazil for the treatment of active TED, a serious, progressive, debilitating and potentially vision-threatening rare autoimmune disease -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced the Brazilian Health Regulatory Agency (ANVISA) has a...

2023-06-25 12:00:43 ET The pharmaceutical industry is caught between a rock and a hard place. If the pricing concerns sparked by the recently enacted Inflation Reduction Act are not enough, the Federal Trade Commission has stepped up scrutiny over merger deals, hurting prospects for a buyou...

2023-06-23 09:46:02 ET Amgen ( NASDAQ: AMGN ) has had some talks with the Federal Trade Commission about settling the regulator's lawsuit to block the Horizon Therapeutics ( NASDAQ: HZNP ) deal. Horizon ticked up 0.6%. The discussions haven't led to a settlement, ...

2023-06-22 17:31:56 ET Six states have joined the Federal Trade Commission's lawsuit to block Amgen's ( NASDAQ: AMGN ) planned $28 billion acquisition of Horizon Therapeutics ( NASDAQ: HZNP ). New York, California, Illinois, Wisconsin, Minnesota and Washington state ...

2023-06-22 17:15:06 ET Five states have joined the Federal Trade Commission's lawsuit to block Amgen's ( NASDAQ: AMGN ) planned $28 billion acquisition of Horizon Therapeutics ( NASDAQ: HZNP ). New York, California, Wisconsin, Minnesota and Washington state joined th...

-- At Week 24, 89% of patients treated with TEPEZZA had a clinically meaningful improvement in proptosis (≥2 mm) compared with 11% of patients receiving placebo -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced positive topline results from its randomized, double-mas...